|1.||Medina, José M: 3 articles (11/2010 - 03/2005)|
|2.||Tabernero, Arantxa: 3 articles (11/2010 - 03/2005)|
|3.||Zou, Fei: 3 articles (05/2009 - 08/2007)|
|4.||Liu, I-M: 3 articles (05/2007 - 03/2005)|
|5.||Cheng, J-T: 3 articles (05/2007 - 03/2005)|
|6.||Cheng, Juei-Tang: 3 articles (11/2006 - 12/2002)|
|7.||Lin, Guanyang: 2 articles (01/2014 - 01/2013)|
|8.||Chen, Mengchun: 2 articles (01/2014 - 01/2013)|
|9.||Ma, Jianshe: 2 articles (01/2014 - 01/2013)|
|10.||Pan, Jianchun: 2 articles (01/2014 - 01/2013)|
03/01/1960 - "Tolbutamide-induced improvement in carbohydrate tolerance of young people with mild diabetes mellitus."
09/01/1970 - "A study of single dose tolbutamide therapy in diabetes mellitus."
05/01/1964 - "[CONTRIBUTION TO THE STUDY OF THE ORAL TOLBUTAMIDE RESPONSE TEST IN THE DIAGNOSIS OF DIABETES MELLITUS]."
03/01/1964 - "[CONTRIBUTION TO THE STUDY OF THE TOLBUTAMIDE TEST IN THE DETECTION OF DIABETES MELLITUS]."
11/01/1963 - "[CONTRIBUTION TO THE STUDY OF THE TOLBUTAMIDE TEST IN THE INVESTIGATION OF DIABETES MELLITUS]."
|2.||Hypoglycemia (Reactive Hypoglycemia)
09/01/1992 - "The present study investigated the teratogenicity of the oral hypoglycemic agent, tolbutamide, using an in vitro approach, and evaluated the role of its main metabolic effect, hypoglycemia. "
07/10/1957 - "Studies on the mechanism of tolbutamide hypoglycemia in animal and human subjects."
07/01/2015 - "In conclusion, tolbutamide treatment during the late embryonic development in broilers resulted in prolonged hypoglycemia in this period and negatively influenced the posthatch performance."
09/01/1992 - "Thus, tolbutamide produces malformation in mouse embryos in vitro at concentrations comparable to those in human serum, and the effects do not appear to be mediated by hypoglycemia. "
03/01/1988 - "Recurrent sulfonylurea induced nocturnal hypoglycemia managed with tolbutamide."
12/29/1960 - "Report of a case with an untoward response to tolbutamide and with a study of the possible mechanism of postoperative hyperglycemia."
01/01/1992 - "Tolbutamide and eight of the studied plants decreased significantly the hyperglycemia as compared with control test (water) (p < 0.05). "
05/01/1961 - "[Hyperglycemia following prolonged administration of elevated doses of tolbutamide to turtles]."
12/01/2007 - "At doses of 200-800 mg/kg, DGTS improved hyperglycemia in the rats, and the hypoglycemic effect of DGTS was comparable to that of tolbutamide. "
03/01/2011 - "The gastric responses to hyperglycemia and tolbutamide were not observed in rats with Kir6.2 small interfering RNA-treated nodose ganglia. "
|4.||Body Weight (Weight, Body)
01/01/2011 - "The extracts were administered for two weeks in different groups whereas tolbutamide (80 mg/kg body weight) was used as reference standard throughout study. "
01/01/2014 - "The results obtained were compared with the reference standard drug Tolbutamide (100mg/kg, body weight). "
05/17/2011 - "Different concentrations of warm BTI (60, 120 and 480 mg/ml), tolbutamide (reference drug: 22.5mg/kg body weight) and water (control) were orally administered to different groups of rats, and hypoglycaemic and antihyperglycaemic activities were assessed. "
10/01/2003 - "Group 2 received tolbutamide 500-mg/Kg body weight. "
01/01/1991 - "In the observational group, tolbutamide concentration depended significantly on the daily dose, time from dose to sampling, body weight, and age. "
11/01/1993 - "The purpose of this study was to determine if tolbutamide, a drug known to decrease gluconeogenesis in diabetes, could decrease gluconeogenesis in hepatocytes isolated from tumor-bearing rats. "
07/01/2008 - "CYP2C9 activity as measured by apparent oral clearance and urinary metabolic ratio following oral tolbutamide appear similar in people with and without cancer. "
11/01/1993 - "Tolbutamide inhibits gluconeogenesis in the tumor-influenced hepatocyte."
07/01/2013 - "Cancer mortality was markedly reduced in the patients on gliclazide and tolbutamide treatment. "
01/01/1967 - "[The effect of tolbutamide on blood cholesterol levels in tumor patients]."
|3.||Blood Glucose (Blood Sugar)
|4.||Hypoglycemic Agents (Hypoglycemics)
|9.||Growth Hormone (Somatotropin)
|10.||Somatostatin (Somatotropin Release-Inhibiting Factor)
|3.||Carbohydrate-Restricted Diet (Low Carbohydrate Diet)